BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2002
View Archived Issues
SkyePharma and GeneMedix to develop extended-release interferon alfa-2b
Read More
Texas Biotechnology presents mid-year update
Read More
Xenical improves weight loss and glycemic control in type 2 diabetes patients on metformin
Read More
VaxGen and Genentech revise AIDS vaccine candidate agreement
Read More
Inhibitors of ubiquitin ligases as potential new anticancer agents
Read More
Antisoma's vascular targeting agent well tolerated in phase I trials
Read More
Heat-activated drug therapy for prostate cancer enters clinical trials
Read More
U.K. introduction for Amgen's novel rheumatoid arthritis therapeutic
Read More
Buprenorphine matrix patch for chronic pain relief launched in U.K.
Read More
Biochemical profile of SM-13496, an atypical antipsychotic, characterized in vitro and in vivo
Read More
Antipsychotic effects demonstrated in patients for dopamine stabilizer OSU-6162
Read More
Preclinical profile of Lu-35-138 described at CINP congress
Read More
New data on the efficacy and safety of the antidepressant S-20098
Read More
FDA approval for Remicade for remission maintenance of Crohn's disease
Read More
Gleevec submitted in U.S. and E.U. for first-line use in CML
Read More
E.U. approval for Zenapax in pediatric renal transplantation
Read More
Schering AG acquires distribution rights for Testogel in Europe
Read More
Reolysin enters phase I/II in brain cancer
Read More
Adenylyl cyclase inhibitors and their use in congestive heart failure
Read More
Novel PPARalpha agonists in Lilly pipeline
Read More
New antibacterial carbapenems in early development at Sankyo
Read More
GSK claims tachykinin NK2/NK3 antagonists for respiratory disorders
Read More
Bombesin receptor antagonists with potential in sexual dysfunction
Read More